Press release
RNA Based Therapeutics Market Expected to grow at a CAGR of CAGR of 28.5% By Key Players: Quark Pharmaceuticals, Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, Tekmira Pharmaceuticals
RNA Based Therapeutics Market
The Global RNA based therapeutics Market has garnered significant attention in the recent years due to its potential to treat variety of chronic diseases such as cancer, diabetes, AIDS, Tuberculosis and certain cardiovascular conditions.
Despite the restraints, RNA based therapeutics has the potential to grow due to increasing interest exhibited by the pharmaceutical industries for the commercialization of these therapies.
Download Sample PDF copy of this report @ https://www.supplydemandmarketresearch.com/home/contact/491567?ref=Sample-and-Brochure&toccode=SDMRME491567&utm_source=S2
Despite being in the clinical research phase, the RNA based therapeutics is been explored as a promising treatment option for the diseases which are difficult to treat.Development of this therapeutics is based on promising technologies such as RNA interference technology (RNAi), antisense technology and SMaRT technology. RNAi technology and antisense technology together are gaining prominence in the research industry, as these technologies provide base sequence to develop RNA drugs. RNAi technology works by causing destruction of specific mRNA molecules; whereas, antisense technology works by synthesizing strand of RNA from known gene sequence. These newly synthesized RNA strands then itself binds to mRNA and make mRNA inactive. Gene silencing potential of RNA based therapeutics is the primary driver for the growth of this market. The other drivers include target specificity and selectivity of RNAi therapeutics, more intense product focus versus platform technologies and virtual drug development models that enable companies to reduce the research cost. However, critical issues in drug delivery, high cost of research, and high failure rates are some of the major hurdles for the companies working in this field.
This of report focuses on the RNA Based Therapeutics Market in global market, especially in United States, China, Europe, Japan, Southeast Asia, India and more.
The Top key players covered in this study:
Quark Pharmaceuticals
Alnylam Pharmaceuticals
Dicerna Pharmaceuticals
Tekmira Pharmaceuticals
Benitec Biopharma Limited and more….
Market Segment by Type, covers:
Microarrays
Labeling
Purification
Linear amplification
qRT-PCR
Inhibition
RNA Interference (RNAi) technologies
RNA antisense technologies
Market Segment by Applications, can be divided into:
Cardiovascular
Kidney Diseases
Oncology
Infectious diseases
Metabolic disorders
Others
qRT-PCR
Inhibition
RNA Interference (RNAi) technologies
RNA antisense technologies
Enquire before purchase@: https://www.supplydemandmarketresearch.com/home/purchase?code=SDMRME491567
Table of Contents:
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.3 Industrial Chain
1.4 Industry Situation
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.2 Overall Market Performance(Value)
3 Product Application Market
3.1 Overall Market Performance (Volume)
4 Manufacturers Profiles/Analysis
4.1 Quark Pharmaceuticals
4.1.1 Quark Pharmaceuticals Profiles
4.1.2 Quark Pharmaceuticals Product Information
4.1.3 Quark Pharmaceuticals RNA Based Therapeutics Business Performance
4.1.4 Quark Pharmaceuticals RNA Based Therapeutics Business Development and Market Status
4.2 Alnylam Pharmaceuticals
4.2.1 Alnylam Pharmaceuticals Profiles
4.2.2 Alnylam Pharmaceuticals Product Information
4.2.3 Alnylam Pharmaceuticals RNA Based Therapeutics Business Performance
4.2.4 Alnylam Pharmaceuticals RNA Based Therapeutics Business Development and Market Status
4.3 Dicerna Pharmaceuticals
4.3.1 Dicerna Pharmaceuticals Profiles
4.3.2 Dicerna Pharmaceuticals Product Information
4.3.3 Dicerna Pharmaceuticals RNA Based Therapeutics Business Performance
4.3.4 Dicerna Pharmaceuticals RNA Based Therapeutics Business Development and Market Status
4.4 Tekmira Pharmaceuticals
4.4.1 Tekmira Pharmaceuticals Profiles
4.4.2 Tekmira Pharmaceuticals Product Information
4.4.3 Tekmira Pharmaceuticals RNA Based Therapeutics Business Performance
4.4.4 Tekmira Pharmaceuticals RNA Based Therapeutics Business Development and Market Status
4.5 Benitec Biopharma Limited
…….TOC Continued
Canada Office:
302-20 Misssisauga Valley Blvd, Missisauga, L5A 3S1, Toronto
Contact Us
Email- info@supplydemandmarketresearch.com
Website- www.supplydemandmarketresearch.com
Phone Number: +919960204545
About us
We have a strong network of high powered and experienced global consultants who have about 10+ years of experience in the specific industry to deliver quality research and analysis.
Having such an experienced network, our services not only cater to the client who wants the basic reference of market numbers and related high growth areas in the demand side, but also we provide detailed and granular information using which the client can definitely plan the strategies with respect to both supply and demand side.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Based Therapeutics Market Expected to grow at a CAGR of CAGR of 28.5% By Key Players: Quark Pharmaceuticals, Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, Tekmira Pharmaceuticals here
News-ID: 1800295 • Views: …
More Releases from Supply Demand Market Research
South Korea Flounder Market Anticipated to grow at a CAGR of 8% from 2023-2030
The South Korea flounder is anticipated to grow at a CAGR% of 8.0% from 2022-2030. The factors contributing towards the high growth are flounders such as halibut and turbot high-protein and low-calorie food, helps to re-solve the nutritional imbalance from diet because of its rich minerals, carbohydrates and vitamins despite low-calorie. They also offer medical benefits as liver of halibut contains lots of vitamin B1 and B2, which is effective…
Global Flounder Market Anticipated to reach USD 56 Billion by 2030
The global flounder market is anticipated to reach USD 56 Billion by 2030, growing at a CAGR% of 8.0% from 2022-2030. The factors contributing towards the high growth are flounders such as halibut and turbot high-protein and low-calorie food, helps to re-solve the nutritional imbalance from diet because of its rich minerals, carbohydrates and vitamins despite low-calorie. They also offer medical benefits as liver of halibut contains lots of vitamin…
Global Seafood Market Anticipated to reach USD 730 Billion by 2030
The global seafood market is anticipated to reach USD 730 Billion by 2030, growing at a CAGR% of 8.9% from 2022-2030. The factors contributing towards the high growth are increased disposable income, awareness of fish being used as an ingredient in healthy food is growing. USA the government plans to sanction illegal fishing activities, actively promote fair trade, and promote strategies to promote the fishing industry through detailed strategies such…
Robotic Palletizers Market Is Expected to Reach US$11.98 Billion by 2033
The global robotic palletizers market is anticipated to reach $11.98 billion by 2033, presenting a 2023-2033 CAGR of 8.3%. The factors contributing towards the growth include the emerging Industry 4.0, a large scope for AI innovation, an increasing adoption of advanced industrial robotics to improve productivity and safety in manufacturing sectors, and the increasing government initiatives.
The report is highlighted with 122 tables and 96 figures, this 209-page report "Global Robotic…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
